Published in Drug Law Weekly, July 10th, 2007
Dr. Shah, assistant professor for the division of Hematology/Oncology Department of Medicine at the UCSF School of Medicine in San Francisco, CA., will discuss treatment choices, emerging CML therapies, the role of clinical trials and quality of life issues. A question-and-answer period will follow.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.